This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abnova
product type :
antibody
product name :
SELPLG monoclonal antibody, clone HECA-452
catalog :
MAB12604
quantity :
50 ug
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
HECA-452
The same clone is also sold as:
The same clone is also sold as:
- Novus Biologicals: NBP2-80921, NB100-78039
- BD Biosciences: 550407, 555947, 563962, 555946
- BioLegend: 321314, 321317, 321305, 321306, 321309, 321310, 321302, 321313, 321312, 321307, 321308, 321315, 321316, 321311
- Santa Cruz Biotechnology: sc-53514
- OriGene: AM20569PU-N
- Invitrogen: 50-9857-82, 14-9857-82
reactivity :
human, mouse
application :
flow cytometry, immunohistochemistry - paraffin section
product information
catalog id :
MAB12604
product name :
SELPLG monoclonal antibody, clone HECA-452
product description :
Rat monoclonal antibody raised against human SELPLG.
clone name :
HECA-452
isotype :
IgM
gene name :
SELPLG
gene alias :
CD162 CLA PSGL-1 PSGL1
gene description :
selectin P ligand
immunogen :
Stromal preparation from human tonsils.
form :
Liquid
recommend dilutions :
Flow Cytometry. Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (10 ug/mL). The optimal working dilution should be determined by the end user.
storage buffer :
In PBS, pH 7.2 (0.09% sodium azide).
storage instruction :
Store at 4 C. Do not freeze.
note :
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
type clonality :
Antibody
raised in host species :
Rat
antigen species target species :
Human
species reactivity cross reactivity :
Human,Mouse
application key :
IHC-P,Flow Cyt
size :
50 ug
autodate :
12/31/15
updatetime :
1/8/16 11:31
company information
Abnova
9th Fl., No.108, Jhouzih St.
Neihu District. Taipei City
114 Taiwan
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com877-853-6098
questions and comments